Full name
SOLISPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75 - Retail sale of cosmetic and toilet articles in specialised stores
49.41 - Freight transport by road
64.19.Z - Other monetary intermediation
64.20.Z - Activities of holding companies
64.30.Z - Trusts, funds and similar financial entities
64.92.Z - Other credit granting
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
77 - Rental and leasing activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 1,8 | 9,7 | 455,2 |
EBITDA | 1,1 | 1,9 | 9,6 | 398,9 |
Short time liabilities | 6,1 | 12,1 | 14 | 15,2 |
Equity capital | 3,6 | 5,3 | 11,7 | 119,8 |
Operating profit (EBIT) | 1 | 1,8 | 9,5 | 416,7 |
Assets | 9,9 | 17,4 | 26,6 | 52,4 |
Net profit (loss) | 0,9 | 1,7 | 7,4 | 337,7 |
Cash | 2,1 | 4 | 12,5 | 214,3 |
Net income from sale | 42,7 | 66,9 | 108,7 | 62,4 |
Liabilities and provisions for liabilities | 6,3 | 12,1 | 14,9 | 22,8 |
Working assets | 8 | 15,2 | 24,9 | 64,2 |
Depreciation | 0,1 | 0,1 | 0,1 | 24,7 |
% | % | % | p.p. | |
Profitability of capital | 25,4 | 31,6 | 63 | 31,4 |
Equity capital to total assets | 36,6 | 30,5 | 44 | 13,5 |
Gross profit margin | 2,2 | 2,6 | 9 | 6,4 |
EBITDA Margin | 2,5 | 2,9 | 8,8 | 5,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 52 | 66 | 47 | -19 |
Current financial liquidity indicator | 1.3135526180267334 | 1.2537908554077148 | 1.7838022708892822 | 0,5 |
Net dept to EBITDA | -1.47369384765625 | -2.0228424072265625 | -1.2724716663360596 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane